Daisuke Miyaki

909 total citations
24 papers, 505 citations indexed

About

Daisuke Miyaki is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Daisuke Miyaki has authored 24 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 9 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Daisuke Miyaki's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (9 papers) and Liver Disease and Transplantation (6 papers). Daisuke Miyaki is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (9 papers) and Liver Disease and Transplantation (6 papers). Daisuke Miyaki collaborates with scholars based in Japan and Switzerland. Daisuke Miyaki's co-authors include Hiroshi Aikata, Akira Hiramatsu, Kazuaki Chayama, Noriaki Naeshiro, Tomokazu Kawaoka, Shoichi Takahashi, Yoshiiku Kawakami, Michio Imamura, Koji Waki and Yuko Nagaoki and has published in prestigious journals such as Journal of Gastroenterology and Hepatology, Journal of Gastroenterology and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Daisuke Miyaki

22 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisuke Miyaki Japan 15 381 282 137 84 64 24 505
Noriaki Naeshiro Japan 16 390 1.0× 313 1.1× 177 1.3× 78 0.9× 59 0.9× 25 551
Ryusuke Yamaguchi Japan 4 339 0.9× 161 0.6× 234 1.7× 48 0.6× 126 2.0× 5 504
Laura E. Moreno-Luna United States 7 366 1.0× 232 0.8× 143 1.0× 43 0.5× 52 0.8× 10 471
Martin W. James United Kingdom 10 457 1.2× 313 1.1× 188 1.4× 159 1.9× 130 2.0× 23 640
Masamichi Moriguchi Japan 16 376 1.0× 210 0.7× 285 2.1× 31 0.4× 201 3.1× 53 595
Kota Tsuruya Japan 13 206 0.5× 175 0.6× 99 0.7× 54 0.6× 77 1.2× 46 408
Tokio Higaki Japan 16 451 1.2× 287 1.0× 303 2.2× 29 0.3× 217 3.4× 75 691
Hajime Aino Japan 9 211 0.6× 99 0.4× 110 0.8× 55 0.7× 64 1.0× 10 320
Liu Tj Taiwan 9 395 1.0× 187 0.7× 281 2.1× 56 0.7× 105 1.6× 30 557
Judith Maresch Austria 12 193 0.5× 135 0.5× 160 1.2× 33 0.4× 172 2.7× 19 434

Countries citing papers authored by Daisuke Miyaki

Since Specialization
Citations

This map shows the geographic impact of Daisuke Miyaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Miyaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Miyaki more than expected).

Fields of papers citing papers by Daisuke Miyaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Miyaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Miyaki. The network helps show where Daisuke Miyaki may publish in the future.

Co-authorship network of co-authors of Daisuke Miyaki

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Miyaki. A scholar is included among the top collaborators of Daisuke Miyaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Miyaki. Daisuke Miyaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawaoka, Tomokazu, Hiroshi Aikata, Hideyuki Hyogo, et al.. (2015). Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma. Journal of Digestive Diseases. 16(9). 505–512. 37 indexed citations
2.
Honda, Yohji, Yoshiiku Kawakami, Hiromi Kan, et al.. (2014). A second attack of cholestasis associated with erythropoietic protoporphyria was successfully treated by plasma exchange and blood transfusion. Clinical Journal of Gastroenterology. 7(4). 333–337. 7 indexed citations
3.
Honda, Yohji, Tomoki Kimura, Hiroshi Aikata, et al.. (2014). Pilot study of stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma.. PubMed. 61(129). 31–6. 17 indexed citations
4.
Fukuhara, Takayuki, Hideyuki Hyogo, Hidenori Ochi, et al.. (2014). Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus.. PubMed. 61(130). 323–8. 48 indexed citations
5.
Kawaoka, Tomokazu, Hiroshi Aikata, Hiromi Kan, et al.. (2014). Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib. Hepatology Research. 44(13). 1320–1328. 7 indexed citations
6.
Kobayashi, Tomoki, Yoshiiku Kawakami, Akira Hiramatsu, et al.. (2013). A case of acute hepatitis C with hepatitis C virus (HCV) genotype 3a -discussion of IL28-B-. Kanzo. 54(2). 120–127.
7.
Miyaki, Daisuke, Hiroshi Aikata, Hiromi Kan, et al.. (2013). Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy. Journal of Gastroenterology and Hepatology. 28(12). 1834–1841. 17 indexed citations
8.
Naeshiro, Noriaki, Hideaki Kakizawa, Hiroshi Aikata, et al.. (2013). Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long‐term outcomes in 14 patients. Hepatology Research. 44(7). 740–749. 23 indexed citations
9.
Naeshiro, Noriaki, Hiroshi Aikata, Hideaki Kakizawa, et al.. (2013). Long‐term outcome of patients with gastric varices treated by balloon‐occluded retrograde transvenous obliteration. Journal of Gastroenterology and Hepatology. 29(5). 1035–1042. 14 indexed citations
10.
Takaki, Shintaro, Yoshiiku Kawakami, Daisuke Miyaki, et al.. (2013). Non‐invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients. Hepatology Research. 44(3). 280–287. 18 indexed citations
11.
Kawaoka, Tomokazu, Hiroshi Aikata, Eisuke Murakami, et al.. (2012). Evaluation of the mRECIST and α-Fetoprotein Ratio for Stratification of the Prognosis of Advanced-Hepatocellular-Carcinoma Patients Treated with Sorafenib. Oncology. 83(4). 192–200. 55 indexed citations
12.
Nagaoki, Yuko, Hiroshi Aikata, Tomoki Kobayashi, et al.. (2012). Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis. Journal of Gastroenterology. 48(7). 847–855. 14 indexed citations
13.
Kawakami, Yoshiiku, Takashi Nakahara, Mio Tanaka, et al.. (2012). [A case of advanced hepatocellular carcinoma with lung, brain and lymph node metastases recurred 8 years after hepatectomy successfully treated by operation, radiation and systemic chemotherapy using S-1/CDDP].. PubMed. 109(8). 1401–8. 1 indexed citations
14.
Aikata, Hiroshi, Tomokazu Kawaoka, Eisuke Murakami, et al.. (2011). A case report of perforation of the colon during the sorafenib therapy for hepatocellular carcinoma. Kanzo. 52(12). 777–783.
15.
Murakami, Eisuke, Hiroshi Aikata, Daisuke Miyaki, et al.. (2011). Comparison of Sorafenib response evaluation with RECIST, mRECIST and RECICL for hepatocellular carcinoma. Kanzo. 52(5). 322–324. 4 indexed citations
16.
17.
Nagaoki, Yuko, Hideyuki Hyogo, Hiroshi Aikata, et al.. (2011). Recent trend of clinical features in patients with hepatocellular carcinoma. Hepatology Research. 42(4). 368–375. 78 indexed citations
18.
Nagaoki, Yuko, Hiroshi Aikata, Daisuke Miyaki, et al.. (2011). Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy. Journal of Gastroenterology. 46(6). 799–808. 21 indexed citations
19.
Miyaki, Daisuke, Hiroshi Aikata, Koji Waki, et al.. (2011). [Significant regression of a cavernous hepatic hemangioma to a sclerosed hemangioma over 12 years: a case study].. PubMed. 108(6). 954–61. 6 indexed citations
20.
Nagai, Hidenari, Daisuke Miyaki, Masahiro Kanayama, et al.. (2008). Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy. Cancer Chemotherapy and Pharmacology. 62(6). 959–963. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriaki Naeshiro Breakdown of academic impact, for papers by Ryusuke Yamaguchi Breakdown of academic impact, for papers by Laura E. Moreno-Luna Breakdown of academic impact, for papers by Martin W. James Breakdown of academic impact, for papers by Masamichi Moriguchi Breakdown of academic impact, for papers by Kota Tsuruya Breakdown of academic impact, for papers by Tokio Higaki Breakdown of academic impact, for papers by Hajime Aino Breakdown of academic impact, for papers by Liu Tj Breakdown of academic impact, for papers by Judith Maresch
Rankless by CCL
2026